locums nephrology job in north island, new zealand gmedical.com/job/job-3166...
Global Medical Staffing
gmedical.com
Kevan Polkinghorne 🇳🇿
@dialysisbloke.bsky.social
#Nephrologist at Monashhealth Prof of Medicine, Monash University #Haemodialysis #BioStats #Epidemiology Melbourne, Australia #MedSky #NephSky #SkyNeph
@dialysisbloke.bsky.social Applied the VIPAR protocol to a patient with cAMR, first time in our centre. Fingers crossed for positive results 🤞🏻 Just wanted to let you know that it’s being used out there 🤓
✅ New Clinical Guidance for Kidney Stone Management Managing kidney stones effectively requires timely decisions and tailored evaluation. This visual summary highlights key steps from acute presentation to post-stone evaluation:
Delighted to see my Commentary published in the latest issue of #Circulation Journal Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure Disagree? Happy to be challenged 💪🏼 #StopCardiacTests Link to issue: www.ahajournals.org/toc/circ/cur...
Vol 152, No 23 | Circulation
ahajournals.org
Registration now open url.au.m.mimecastprotect.com/s/ZR0QCNLwzj... * Causal Inference with Hidden Confounding * Implementing the Estimand Framework in Clinical Trials * Pairwise and Network Meta-analysis: Fundamentals and Beyond * Cluster Randomised Trials: From Fundamentals to State-of-the-Art
ViCBiostat Summer School 2026
Welcome to the registration page for the 2026 Summer School courses. Full course descriptions can be found on our website:...
url.au.m.mimecastprotect.com
ViCBiostat@vicbiostat.bsky.social · 9mo agoMark your diaries! The ViCBiostat Summer School returns from 13-20 Feb 2026, in Melbourne and online. Courses include causal inference, cluster randomised trials, meta-analysis and the estimand framework. Further details TBA shortly - sign up to our mailing list at www.vicbiostat.org.au #statistics
Stop complaining about pill burden in ESRD! There is no pill you are giving your dialysis patient that has data half as impressive as this study. If they are taking too many pills have them stop any of the dozen pills they are taking with ZEERO data in ESRD. #NephJC
Maybe the most shocking study from #KidneyWk. 🐚From the depths of the oceans to #BlueSky, we're discussing PISCES 🐟 12/2/25 9pm EST. #NephJC Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊? www.nephjc.com/news/pisces-fishoil
Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
nephjc.com
The International Vasculitis Workshop is pleased to announce the full speaker lineup for the 2026 event in Melbourne! Explore the complete list and learn more about each speaker on the Workshop Website: vasculitis-melbourne2026.com/plenary-spea...
The success rate for NHMRC Ideas Grants announced yesterday was just over 8%. That means 11 of every 12 people who applied got rejected. This is a culture changing level of rejection and frankly a point of national shame. This is a crisis for research. I will not rest until we see this resolved.
The program for the 22nd International Vasculitis Workshop has now launched! Filled with amazing plenary speakers and sessions. Visit the website vasculitis-melbourne2026.com/program-full/ and start planning your Workshop!
Up next: It might seem a little fishy, but was a great catch 🎣 #NephJC PISCES, the use of fish oil to decrease mortality in dialysis patients. www.pubmed.ncbi.nlm....
Mark your diaries! The ViCBiostat Summer School returns from 13-20 Feb 2026, in Melbourne and online. Courses include causal inference, cluster randomised trials, meta-analysis and the estimand framework. Further details TBA shortly - sign up to our mailing list at www.vicbiostat.org.au #statistics
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure. ja.ma/47A5Gdd
Final Chance! Early bird registrations for the International Vasculitis Workshop 2026 close 14 November - and they won’t be extended again. Register at vasculitis-melbourne2026.com/registration/
Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure. #KidneyWK @asnkidney.bsky.social ja.ma/4oV4DtU
In PISCES, daily n–3 fatty acids cut serious cardiovascular events in dialysis patients by nearly half (HR 0.57). Fish oil clearly had bigger fish to fry than placebo: fewer MIs, strokes, cardiac deaths without extra adverse catches @nejm.org #kidneywk sim publication www.nejm.org/doi/full/10....
Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis | NEJM
Cardiovascular disease is the leading cause of death in patients receiving hemodialysis, yet effective preventive therapies remain limited. Supplementation with n−3 polyunsaturated fatty acids, esp...
nejm.org
Shocking first high impact trial of the day. Fish oil reduces CV events in dialysis patients! #Pisces #kidneywk Simultaneous pub in NEJM www.nejm.org/doi/full/10....
Very proud to have lead the Australian arm of PISCES. Huge thanks for Charmaine Lok for the collaboration.
NEJM.org@nejm.org · 9mo agoIn the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo @asnkidney.bsky.social | #KidneyWk
Make the most of Melbourne while visiting for the 22nd International Vasculitis Workshop! Explore hidden laneway cafes, explore the coast or unwind in the Royal Botanic Gardens. Check out the LOC Melbourne Guides: vasculitis-melbourne2026.com/loc-melbourn...
We’re thrilled to welcome Professor Stephen McDonald to the International Vasculitis Workshop 2026! A globally respected expert in vasculitis and nephrology, Prof McDonald brings invaluable insight and experience to the program. Register today at vasculitis-melbourne2026.com
happening tomorrow! @dialysisbloke.bsky.social will be musing on vascular access for #NephGR at @uottawa.ca and @ottawahospital.on.ca
Should we be considering the variability of a person's BP? Growing evidence that more variability is linked to poor outcomes. Maybe something for the 2033 BP guidelines... Long‐Term Blood Pressure Variability and Physical Performance in Older Adults - onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
Last chance everyone! Submit your abstract and join the over 55 invited international speakers at the Workshop #vasculitismelbourne2026 Case reports and series welcome And remember the new Young Invstigator Award Session. See you in 2026.
ANZVASC@anzvasc.bsky.social · 11mo agoWe’re giving you more time to share your work at the upcoming International Vasculitis Workshop. The new deadline to submit your abstract is 29 September 2025! Don't miss your opportunity, submit today at vasculitis-melbourne2026.com/call-for-abs...
Amazing #ANZSN meeting in Perth. First class science (🤯 young investigators), ideas for future meetings, and caught up with friends and colleagues. Melbourne for the vasculitis-melbourne2026.com next!
IVW 2026 | 22nd International Vasculitis Workshop
Join the 22nd International Vasculitis Workshop, a leading event dedicated to advancing research, treatment, and understanding of vasculitis. Connect with global experts, researchers, and practitioner...
vasculitis-melbourne2026.com
@nephjc.bsky.social @lastwalsh.bsky.social just presented ACHIEVE results at #ANZSN. Here’s a some details of country differences not in the main paper
Excellent summary of the ACHIEVE trial from @drsaivani.bsky.social & @thekidneywhisperer.bsky.social #NephJC chat tomorrow www.nephjc.com/news/achieve
In ESRD is spironolactone an overACHIEVEr? — NephJC
This week, we will discuss the ACHIEVE trial. Will spironolactone achieve CV benefits in ESRD?
nephjc.com
Prof Liz Lightstone giving us a fantastic update on Lupus Nephritis at #ASNZSN 2025 @kidneydoc101.bsky.social
